DOI:
10.1055/s-00000085
The Thoracic and Cardiovascular Surgeon
LinksClose Window
References
Le Cesne A, Judson I, Crowther D. et al
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocytemacrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.
J Clin Oncol 2000; 18: 2676-2684
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.